Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Orthostatic Intolerance
NCT00262470Phase 2Active, not recruiting
- Start
- Apr 1997
- Primary completion
- Dec 2029
- Modality
- Peptides, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 2 trial of acetazolamide, atomoxetine, Clonidine Lauriad, entacapone, indomethacin and 9 more in orthostatic intolerance and tachycardia (20 arms). Primary endpoint: Increase in heart rate with standing. Started Apr 1997; status: active, not recruiting.
02
Drugs
acetazolamideatomoxetineClonidine Lauriadentacaponeindomethacin
03
Conditions
orthostatic intolerancetachycardia
Beyond the preview
Go deeper on NCT00262470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262470.